-
Blockbuster Deal: Cstone Pharmaceuticals Partners with Ewopharma to Expand Global Reach of Sugemalim...
Cstone Pharmaceuticals, a leading biopharmaceutical company focused on oncology, has announced a strategic commercial partnership with Ewopharma, a pr...
2024-05-28 16:33 -
The Clash Between Science and Capital: The Dramatic Plunge of Akeso Biopharma
In the ever-evolving landscape of the pharmaceutical industry, the delicate balance between scientific progress and financial expectations has been th...
2024-05-28 16:30 -
Soaring Chinese Pharma: CSPC PHARMA's Q1 Revenue Jumps 11.5%, MediLink Therapeutics Partners with Bi...
CSPC PHARMA, a leading domestic player, has reported a remarkable 11.5% year-over-year increase in its first-quarter revenue, showcasing the resilienc...
2024-05-28 16:25 -
Ambitious Moves: AstraZeneca's Transformative Strategies for Global Dominance
The AstraZeneca's recent activities, paint a picture of a pharmaceutical giant determined to drive innovation and expand its market reach.
2024-05-27 16:35 -
Global Top 10 Best-Selling Orphan Drugs in 2028: Emerging Trends and Insights
This article delves into a comprehensive analysis of the predicted top 10 global orphan drug sales in 2028, providing valuable insights for industry s...
2024-05-27 16:33 -
Pfizer's Cost-Cutting Mission: Doubling Down on Savings
In a relentless effort to streamline its operations, Pfizer has unveiled a new round of cost-cutting measures that aim to save the pharmaceutical gian...
2024-05-24 16:15 -
Biogen's $1.8 Billion Acquisition Bolsters Immunology Portfolio
On May 22nd, 2024, the biopharmaceutical company Biogen announced its acquisition of HumanImmunology Biosciences (HI-Bio) for a staggering $1.8 billio...
2024-05-24 16:14 -
Breakthrough Approval for AK112: Akeso Biopharma's $5 Billion Licensing Deal Reshapes China's Lung C...
In a significant development for the Chinese pharmaceutical industry, Akeso Biopharma's anti-PD-1/VEGF-A bispecific antibody, AK112, has been approved...
2024-05-24 16:14 -
CasymChem's European Expansion: Acquiring Pfizer's CDMO Facility in the UK
Pfizer, for instance, announced in 2023 that it would reduce its operating costs by $3.5 billion, which inevitably involves layoffs.
2024-05-23 15:40 -
Pharmaceutical AI Firm in Crisis: 25% Workforce Cuts, 80% Stock Plunge, Shareholder Litigation
In the ever-evolving landscape of the pharmaceutical industry, the once-celebrated AI-driven drug discovery company Exscientia has found itself embroi...
2024-05-23 15:35
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- German Chemical Industry Outpu... Sep 15, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- ExxonMobil Eyes $1 Billion Pet... Sep 16, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
